Dieppe, NB -- July 16, 2018 -- InvestorsHub NewsWire -- (CBI: TSX-V) -- Colibri Resource Corporation (“Colibri” or the “Company”) wishes to announce assay...
Colibri Resource Corporation Announces Second Batch Results from Drilling at Pilar Gold Project DIEPPE, NB -- May 31, 2018 -- InvestorsHub NewsWire -- (CBI: TSX-V) – Colibri...
Colibri Resource Corporation Announces Initiation of Phase 1 Drilling at Pilar DIEPPE, N.B. -- March 21th, 2018 -- InvestorsHub NewsWire -- (CBI: TSX-V, CRUCF:USOTC) – Colibri...
Dieppe, NB -- March 5, 2018 -- InvestorsHub NewsWire -- (CBI: TSX-V) – Colibri Resource Corporation ("Colibri" or the "Company") is very pleased to announce that, as a result of strong...
YAVNE, Israel, June 5, 2013 (GLOBE NEWSWIRE) -- Andromeda Biotech Ltd. announces the results from an Extension Study to its Phase III Clinical trial in type 1 diabetes patients treated with...
TEL AVIV, Israel, Sept. 24, 2012 (GLOBE NEWSWIRE) -- Clal Biotechnology, (TASE:CBI), a leading investment company in the field of life sciences, is pleased to announce that the Committee for...
NEW YORK, Nov. 28 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) will launch trading in options on Tuesday, November 29, 2005 on the following American Stock Exchange and New York...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.005 | -16.6666666667 | 0.03 | 0.03 | 0.02 | 61138 | 0.02727664 | CS |
4 | -0.01 | -28.5714285714 | 0.035 | 0.04 | 0.02 | 83725 | 0.02899151 | CS |
12 | -0.025 | -50 | 0.05 | 0.05 | 0.02 | 51582 | 0.03509155 | CS |
26 | -0.035 | -58.3333333333 | 0.06 | 0.06 | 0.02 | 52411 | 0.04452093 | CS |
52 | -0.025 | -50 | 0.05 | 0.065 | 0.02 | 48936 | 0.04609446 | CS |
156 | -0.075 | -75 | 0.1 | 0.11 | 0.02 | 42424 | 0.05722248 | CS |
260 | -0.04 | -61.5384615385 | 0.065 | 0.17 | 0.02 | 68888 | 0.07957248 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales